Moreover, EGFR alteration has been proposed to have immunologic roles in GBMs; EGFR mutation governs the vascular and immune microenvironments by mediating the trans‐differentiation of glioma stem cells into pericytes.49 The gene discussed is EGFR; the disease is glioma.